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Abstract
Cancer is projected to become a leading cause of morbidity and mortality in low-income and 
middle-income countries in the future. However, cancer incidence in South Africa is largely 
under-reported because of a lack of nationwide cancer surveillance networks. We describe present 
cancer surveillance activities in South Africa, and use the International Agency for Research on 
Cancer framework to propose the development of four population-based cancer registries in South 
Africa. These registries will represent the ethnic and geographical diversity of the country. We 
also provide an update on a cancer surveillance pilot programme in the Ekurhuleni Metropolitan 
District, and the successes and challenges in the implementation of the IARC framework in a local 
context. We examine the development of a comprehensive cancer surveillance system in a middle-
income country, which might serve to assist other countries in establishing population-based 
cancer registries in a resource-constrained environment.
Introduction
Non-communicable diseases (NCDs) are the leading cause of deaths worldwide, with 80% 
of NCD-related deaths occurring in low-income and middle-income countries (LMICs).1 
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Among NCDs prioritised for action at the UN General Assembly on NCDs in 2011 were 
cardiovascular disease, diabetes, chronic respiratory disease, and cancer.1 Cancer is 
projected to become a leading cause of morbidity and mortality in developing countries in 
the near future,2 with an increase from 6·1 million new cases in 2012 to 9·9 million new 
cases in 2030.3
Cancer is under-reported in South Africa because of the lack of a comprehensive cancer 
surveillance system. The implementation of population-based registration in South Africa is 
in its infancy, which presents an ideal opportunity to review the challenges and outcomes of 
the process thus far.
South Africa is a medium-sized country, divided into nine provinces, with a population of 
just over 54 million people.4 The country’s complex political history has shaped health-care 
service provision and the present disease burden,5,6 with health-care services available from 
both public and private facilities. Although most South Africans (83%) use public health-
care services, private health care accounts for 43% of total South African health 
expenditure.7
As with other LMICs, South Africa has a shortage of qualified health-care professionals. In 
2011, roughly 162 630 health-care professionals were registered with the Health Professions 
Council of South Africa,8 excluding nurses, pharmacists, and pharmacy assistants. For 
comparative reasons, South Africa and Chile are considered peer countries since both are 
middle-income countries with dual health-care systems (public and private), high private 
health-care expenditure, a primary health-care driven public health system, and both 
recognise the need for health-care reform.9 Despite similarities, South Africa has 5·4 doctors 
per 10 000 population, whereas Chile has 15·7 doctors per 10 000 population.8 In 2011, the 
number of South African medical specialists per 10 000 population was 1·96 (with 
substantial variation per province), compared with 4·65 per 10 000 in Chile. In South Africa, 
57% of health-care specialists are estimated to engage in private practice, which serves only 
17% of the population.7,10 Thus, the already disadvantaged 83% of the population who rely 
solely on public health care have access to disproportionately fewer health-care services. 
Oncology healthcare workers registered with the Health Professions Council of South Africa 
in 2014, distributed in both the public and private health-care system, are listed in the table. 
Although the table shows a combined listing, many oncology personnel practise only in the 
private health-care system.
Currently, South Africa is experiencing a health shift with an increasing burden of NCDs in 
addition to already existing health-care issues.11 Since 1990, South Africa has seen an 
increase in both morbidity and mortality as a result of the increasing burden of HIV and 
AIDS, other communicable diseases, NCDs, and trauma, which disproportionately affect 
lower socioeconomic groups.5–7 Cancer is no exception, with 112 921 new cases of cancer 
predicted to be diagnosed in South Africa in 2030 compared with just 77 440 in 2012.3
In view of the expected cancer burden growth in the future, a national cancer surveillance 
system is needed to track incidence trends, plan for screening and diagnostic services, direct 
health-care system resources, and assess cancer prevention activities. We discuss the history 
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and current status of present surveillance systems in South Africa, and present a rationale for 
developing a new system for routine cancer surveillance by using the International Agency 
for Research on Cancer (IARC) framework for implementation of four population-based 
cancer registries.12 Furthermore, the needs for implementation and sustainability of this new 
system will be examined.
Present cancer surveillance systems in South Africa
Cancer surveillance data for South Africa are provided by three cancer registries: the South 
African National Cancer Registry (NCR), the Eastern Cape Province Cancer Registry, and 
the South African Paediatric Tumour Registry.
The South African NCR
The present NCR was established in 1986 as a national, pathology-based cancer registry at 
the South African Institute for Medical Research (now the National Health Laboratory 
Service) as a collaborative venture with the Cancer Association of South Africa and the 
National Department of Health. The NCR is the only source of national cancer statistics and 
incidence data in South Africa, collecting data and analysing cancer cases diagnosed in 
pathology laboratories (both public and private) nationwide and reporting annual cancer 
incidence stratified by sex, age, and ethnic groups. The NCR’s methods follow the 
recommendations of IARC and have been described previously.13 The NCR has an archive 
of more than 1·2 million cancer records in its database and adds about 55 000 new records 
per year.
Despite its early success, the challenges the South African NCR has encountered might 
provide valuable lessons for other LMICs that may also wish to establish cancer surveillance 
programmes. The position of Director of the NCR was vacant from 2002 to 2009 because of 
funding constraints to recruit an appropriate candidate. Appropriate leadership is essential to 
ensure the strategic direction of the cancer registry, promote research activities, and 
encourage international collaborations and confidence in the registry. From 2005 to 2010, 
some private laboratories did not submit data as a result of concerns regarding the reporting 
of confidential patient data to an organisation without the necessary legislative mandate. 
However, these data accounted for a very small proportion of reported cases.13 During the 
past decade, the HIV and tuberculosis epidemics in South Africa have resulted in a re-
direction of resources away from NCDs, which restricted operations that could be carried 
out by the NCR. As a result, the NCR continued to collect most pathology reports through 
low-cost passive surveillance activities. Due to this restriction on services, the NCR was 
unable to capture, code, and analyse data efficiently, resulting in a 10 year backlog of 
incidence reports.
Improvements, including the repositioning of cancer surveillance as a national health 
priority, stable NCR leadership (with an executive director and deputy director appointed 
during 2009–10), and extended collaborations and partnerships, have enabled the NCR to 
substantially reduce the backlog. Funding has been secured to recruit new staff, including 
six additional coders, a biostatistician, and an information technology (IT) developer (on a 
contract basis to interface NCR IT systems with its partners). With the additional staff, the 
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backlog is expected to be within internationally accepted lag times for cancer registration by 
2015–16. Internal quality control mechanisms have been implemented and the registry has 
increased its research output through collaborations with the IARC and the Centers for 
Disease Control and Prevention (CDC) in the USA. Through mentoring and technical 
support from the CDC’s Division of Cancer Prevention and Control, the NCR has been able 
to refine its research focus, mine the available data, and plan additional reports for 
publication.
In 2008, 55 286 new cases of cancer were reported to the NCR (52% of these cases were in 
women and girls).14 Overall, the lifetime risk for cancer is one in eight for men and one in 
nine for women in South Africa. Age-standardised incidences for the top ten cancers in men 
and women for 2008 are shown in the figure, excluding basal and squamous cell carcinomas 
of the skin and cancers with an unknown primary site. The top five primary cancer sites for 
women and girls were breast, cervical, uterine, colon and rectum, and Kaposi’s sarcoma, 
whereas the top five primary cancer sites for men were prostate, lung, colon and rectum, 
oesophagus, and Kaposi’s sarcoma. Although variation was seen across subpopulations, the 
most noteworthy finding was the high incidence of cervical cancer in black women and girls 
and the high incidence of Kaposi’s sarcoma (linked to HIV infection) in both black men and 
boys, and black women and girls. Kaposi’s sarcoma was the second most common cancer in 
black men and boys and third most common cancers in black women and girls.14 However, 
there are limitations to this pathology-based data as the number of clinically diagnosed cases 
may have been underestimated, and pathology-based data was not linked to mortality data.
Eastern Cape Province Cancer Registry
In 1981, the Medical Research Council of South Africa established a small population-based 
cancer registry in the former Transkei region of the Eastern Cape Province.15 The 
Programme on Mycotoxin and Experimental Carcinogenesis has since become known as the 
Eastern Cape Province Cancer Registry. The registry was initially developed to investigate 
oesophageal cancer incidence, but has expanded to include all diagnosed cancers.16 Just 
over 1 million people in eight magisterial districts are covered by the registry,17 which 
includes 15 hospitals and one public health-care laboratory.16 The Eastern Cape Province 
Cancer Registry is not networked to the NCR, and does not report to it at present.
The registry reported 2808 malignancies from 2003 to 2007, with 60·3% of these cancers 
diagnosed in women and girls. About 68% of cases were histologically or cytologically 
confirmed, highlighting the high availability of pathology services in South Africa. 
However, 54% of these cases were recorded in hospitals outside the catchment area, 
suggesting poor availability of cancer diagnostic and management services in the largely 
rural area of the Eastern Cape, as well as highlighting the high mobility of its population.17
The most common cancers in this region were oesophageal, prostate, and lung cancers in 
men and oesophageal, cervical, and breast cancers in women. This region of South Africa 
has some of the highest oesophageal cancer incidence rates in the world, and accounts for 
the difference between the Eastern Cape Province Cancer Registry top cancer rankings and 
the NCR data.17,18
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Limitations of this registry include a high proportion of the black population living a non-
urbanised lifestyle. This might explain the differences in patterns of cancer reported for the 
national population, as other populations and socioeconomic groups are under-represented in 
the Eastern Cape sample. The structure of the catchment population is characteristic of a 
migrant community, with an excess of older women and children, and a shortage of working 
age adults, particularly men.16 Most migrant workers are thought to seek health care in their 
province of work rather than their rural home province, resulting in a shortfall in the number 
of cancers reported, especially for men, in the Eastern Cape Registry.16 Additionally, HIV 
prevalence among South African women is highest nationally in the economically active age 
group of 30–34 years.19 In view of the deficit of working age adults in the catchment 
population of this registry, the pattern of HIV-related cancers might not be a true 
representation of South Africa as a whole. Finally, the scarcity of screening and diagnostic 
health-care services in this area suggests that there is an under-diagnosis of cancers in 
general. Nevertheless, this registry provides a unique and valuable insight on cancer 
epidemiology in a difficult-to-reach population. The quality of these data has been validated 
through its inclusion in the 2013 IARC publication.20
South African Paediatric Tumour Registry
The South African Paediatric Tumour Registry was initiated in 1987 to collect and classify 
malignancies in individuals younger than 15 years. Since other registries reported adult and 
childhood cancers together, specific nuances in the epidemiology of childhood cancers 
might have been missed; therefore, there was a need for a childhood-specific cancer registry. 
The registry acts as a central repository for paediatric oncology units across the country, 
including oncologists and other interested parties in private practice. The South African 
Paediatric Tumour Registry has previously been hosted at various paediatric oncology units 
in the country and, at the time of writing, is currently at Stellenbosch University in the 
Western Cape Province of South Africa. It is staffed by four part-time employees and is 
fully funded by private donors.21 An informal arrangement exists between the South African 
Paediatric Tumour Registry and the NCR whereby cases not reported to the NCR are 
provided by the South African Paediatric Tumour Registry for individuals younger than 15 
years.
Annually, 500–700 cases are reported to the South African Paediatric Tumour Registry. 
Between 2003 and 2007, the registry reported yearly incidence figures between 33·4 and 
47·2 cases per million, with leukaemia being the most common cancer in children aged 0–14 
years.21 However, the number of childhood cancers might be lower than expected because 
of an under-reporting of cancer diagnosis for this patient population.21 This under-reporting 
might be the result of children dying before they seek health care, a failure to refer children 
to oncology centres at the appropriate time, and a failure to include cancers in the 
differential diagnosis. Low reporting figures could also be a result of childhood cancer cases 
being treated by adult oncologists in under-served areas, inadequate reporting from other 
paediatric subspecialists, and incomplete reporting from private paediatric oncologists.21 
Although data from the South African Paediatric Tumour Registry are regularly presented at 
national and international meetings, formal reporting on a routine basis would help clarify 
the epidemiology of childhood cancers across the country. However, the South African 
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Paediatric Tumour Registry remains an important source of data for researchers in the 
paediatric oncology field since it records clinical cases treated by paediatric oncologists.
Rationale for the South African cancer surveillance programme
Present cancer surveillance systems in South Africa are restricted to pathology-based 
national surveillance programmes and smaller, independent clinical-based registries that do 
not formally report to the NCR. These registries do not have the resources to collect robust 
cancer incidence data, which can be used to estimate national cancer incidence. As a result, 
policy makers and researchers are committed to implementing a network of population-
based cancer registries representative of the ethnic and geographical diversity of the South 
African population, and provide a reliable indication of cancer incidence for the entire 
country.
The following sections outline the environmental changes that provided the platform for the 
development and implementation of population-based cancer registries, the practical 
challenges faced, and the lessons learned.
Population-based cancer registries in South Africa: an update
Policy, systems, and environmental changes
In 2011, the South African Department of Health created Regulation No 380 of the National 
Health Act (Act 61 of 2003),22 which formally established the NCR as its delegated agency 
for the collection of cancer surveillance information. Importantly, the regulation made 
cancer a reportable disease with every health-care worker obligated to report confirmed 
cancers to the NCR. The regulation raised the profile of cancer surveillance and the NCR in 
South Africa, and provided legislative protection for reporting sources. To ensure that South 
African cancer surveillance activities were in line with the rest of the world, the regulation 
mandated the NCR to establish population-based cancer registries for the country. Together 
with the regulation, a data collection form was published necessitating the provision of 
patient demographic, clinical, and risk factor information, including HIV status, and a 
detailed description of tumour pathology.
In 2012, the appointment of the National Advisory Committee on the Prevention and 
Control of Cancer affirmed the commitment of the Ministry of Health to cancer health-care 
reforms. Representation from the NCR presented the opportunity for policy makers to share 
solutions to cancer surveillance issues. Since then, the NCR has become a permanent agenda 
item at the committee’s meetings.
Imminent reforms in health-care financing in South Africa, in the form of the National 
Health Insurance,23 aim to improve access to health care for all South Africans. This reform 
has the potential to improve cancer screening and diagnosis, resulting in more complete 
cancer surveillance estimates from the NCR.
Public–private partnerships were crucial in the formation of population-based cancer 
registries in the resource-restricted public health-care sector in South Africa. The NCR 
developed a 10 year business plan for a phased-in approach towards four fully operational 
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population-based cancer registries. This business plan was proposed to the pharmaceutical, 
medical insurance, and private laboratory industries in South Africa to raise funds. Many 
private partners recognised the value of population-based cancer surveillance data for the 
South African public and private health-care systems and committed support to this 
initiative with no expectation other than the production of reliable cancer surveillance data 
in South Africa. However, the sustainability of the cancer surveillance programme is reliant 
on a long-term funding commitment from both South Africa’s National Department of 
Health and private partnerships.
Appropriate and effective leadership is essential for the success of national cancer 
surveillance. After 7 years without a director, the NCR appointed an executive director in 
2009, ensuring a new strategic direction for the organisation, improving work processes and 
raising staff morale. Manual, labour-intensive tasks were replaced by electronic methods, 
and relationships with private sector laboratories were renewed. Additionally, the NCR 
established relationships with international organisations such as IARC, the African Cancer 
Registry Network, which serves as IARC’s regional Hub for Cancer Registration in Africa, 
and the CDC in the USA, which has provided research support and mentoring to NCR 
researchers. Support from these organisations has been crucial in the planning of cancer 
surveillance activities and research agenda by the NCR.
Finally, the Ministry of Health has committed to establishing South Africa’s first National 
Public Health Institute, incorporating surveillance on communicable diseases and NCDs, 
and injury prevention.24 The institute will be modelled on the CDC in the USA. The NCR 
will be a core element of this new institute, benefiting from and contributing to the skills 
available in other surveillance divisions.
Legislative and system changes have provided a supportive environment for the 
establishment of population-based cancer registries in South Africa and the revitalisation of 
the pathology-based cancer surveillance system.
Implementation
We expect that the implementation of population-based cancer registries will provide the 
best resource for national incidence estimates in South Africa, and will mitigate the 
limitation of present pathology-based surveillance systems caused by the under-reporting of 
cancers that have not been biopsied.
The establishment of population-based cancer registries in South Africa was based on the 
framework provided by IARC.12,25 In principle, the framework suggests that population-
based cancer registries should be established within a clearly defined district with a distinct 
catchment area and known population size.25 Ideally, the district should include the referral 
hospital or hospitals. The catchment population should be representative of the geographical 
and ethnic diversity of the country.
The population of South Africa is large and ethnically diverse. Overall, 80% of the South 
African population is black African, 8·8% mixed race (ancestral components including 
Khoisan, African, European, and Asian),26 8·4% white, and 2·5% Asian or Indian. The 
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distribution of population groups, disease burdens, mortality, and life expectancy vary by 
province.4 The South African population-based cancer registry programme was able to meet 
some, but not all, of the IARC criteria in the local context.
In view of the size of the South African population, an estimated minimum of four 
population-based cancer registries will be needed to confidently extrapolate national cancer 
incidence. Each registry will have a catchment population of between 1·5 and 3 million 
inhabitants, and, together, will represent fully the ethnic and geographical diversity of the 
South African population. These regional registries will report annually to the NCR. 
Districts in the Western Cape province (largely white and mixed-race communities), and the 
Eastern Cape province (rural communities), a National Health Insurance Pilot Site23 (a 
resource-poor setting), and the Ekurhuleni Metropolitan District (ethnically and 
socioeconomically diverse communities) were selected as the sites for the four population-
based cancer registries. Plans for the Eastern Cape province consist of increasing capacity of 
the present Eastern Cape Province cancer registry.
Challenges and opportunities
The first population-based cancer registry in the Ekurhuleni district was established in 2012, 
and revealed many of the challenges and successes of attempting to implement the IARC 
framework for population-based cancer registries in South Africa.
Ekurhuleni Metropolitan Municipality in the Gauteng Province is home to 3·1 million 
inhabitants.2 Of the total population, 79·0% are black African, 15·9% are white, 2·7% mixed 
race, and 2·2% Indian. Women and girls represent 49·3% of the population.27 The district 
has six government hospitals and eight private health-care facilities. Patients using public 
health-care facilities are diagnosed in the district but referred outside of the district for 
investigation and treatment to three tertiary or quaternary academic hospitals in Gauteng. 
Thus, case ascertainment for this population-based cancer registry will need data collection 
outside the municipality at the three large referral hospitals (between 800 and 3200 beds per 
hospital). This will probably be the case for many of the population-based cancer registries 
in South Africa because of the arrangement of the South African health system.
Access to private hospitals and oncology practices has proved a challenge for the NCR in 
Ekurhuleni. Although large hospital groups have been receptive to the idea of data 
provision, independent practitioners have been less enthusiastic to provide data. Issues of 
patient consent, confidentiality, and time needed to accommodate data collection have been 
raised with the NCR. Considerable relationship building and education is needed between 
the NCR and individual private practitioners to allow NCR staff access to the practices.
Active surveillance will be used in the Ekurhuleni population-based cancer registry, with 
field workers visiting private and public hospitals to extract relevant information about 
confirmed cases of cancer from patient records. Despite the legislation being in place, and as 
the NCR has experienced, passive surveillance that relies on health-care workers to notify 
patients with cancer has been unsuccessful. In the future, the support of local health-care 
departments will be invaluable in facilitating robust reporting.
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The absence of central electronic information systems in public health-care sector creates a 
challenge to case ascertainment. Two options are available: to access files in the central 
medical records department of each hospital or to collect discharge files from each ward 
before they are stored in central medical records. The second option, although more labour 
intensive (requiring field workers to visit each ward), is preferred for completeness of 
registration, since locating hard copy medical files in the records department of larger 
hospitals can often be challenging.
Data capturing will ideally be accomplished using the IARC free software, CanReg. 
However, this software will need substantial modification of the data input section to 
accommodate the reporting form legislated for South Africa.
An NCR champion has proved to be very useful in the development of population-based 
cancer registries. In the development of a population-based cancer registry in the Ekurhuleni 
Metropolitan Municipality, this has been a senior oncologist with a special interest in cancer 
registration who has a good network of colleagues in the district. The individual is 
responsible for encouraging colleagues to report cancer cases, raising awareness of cancer 
registration, and answering queries about registry entries. In the future, a regional expert 
committee will be convened to help access data sources, encourage reporting, and provide 
scientific advice to a district’s population-based cancer registry.
Search strategy and selection criteria
We used Pubmed and Google Scholar to search for abstracts, articles, policy documents, 
and reports describing present and previous cancer surveillance activities in South Africa 
and related health-care legislation between 1994 and 2014. Only articles published in 
English were included. We searched for the following keywords: “cancer registration”, 
“cancer registry”, “cancer policy”, “cancer surveillance”, “population-based cancer 
registration”, “non-communicable diseases”, “NCD’s”, “Eastern Cape Province Cancer 
Registry”, “South African Paediatric Tumour Registry”, “childhood cancer”, and “South 
Africa”. We identified peer-reviewed published work with possible descriptions of 
cancer surveillance or registration systems and results for South Africa. Additionally, we 
identified policy and legislative documents directly or indirectly affecting cancer 
surveillance and cancer registration in South Africa. We manually searched for cancer 
policy or legislation in South Africa, which we cross-referenced for identified articles. 
We included studies relevant to the scope of the Series paper and the local context.
Outcomes
The model we have produced of four independent but linked population-based cancer 
registries reporting to the NCR will hopefully result in the production of nationally 
representative cancer incidence estimates for the country. The cancer burden will be 
described according to specific cancer type, geographical location, ethnic origin, age, and 
sex. Additionally, depending on the availability of the information in the medical records, 
risk factor information such as HIV status, occupation, alcohol, and smoking history will be 
available. However, the usefulness of these risk factors will need to be tested in the 
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Ekurhuleni population-based cancer registry. To be useful for cancer risk analysis, variables 
will need to be available for 80–90% of patients.12 We expect HIV status to be the most 
widely available risk factor in medical records, with other risk factors having poorer 
availability. Furthermore, simple treatment information is requested in the notification form 
with a tick box for different treatment modalities.
The data provided by the population-based surveillance system could allow for policy 
development and appropriate planning and placement of cancer diagnostic and management 
facilities. In South Africa, the use of data to assess primary prevention programmes such as 
the implementation of the human papillomavirus (HPV) vaccination, which was rolled out in 
South Africa for the first time in March, 2014, is particularly important.28 Population-based 
cancer registry data might provide an understanding of the long-term effect of HPV 
vaccination through comparison of baseline and post-vaccination cervical cancer incidences. 
Additionally, population-based cancer registries could provide the first population-level data 
to track cancer treatment, which will assist in the development of standardised treatment 
regimens for various cancers.
Monitoring and evaluation
The population-based cancer registries will strive to meet IARC quality standards. 
Monitoring and assessment will include the generally accepted variables of completeness, 
comparability, validity, and timeliness.29 Semiquantitative methods, such as the mortality–
incidence ratio and the proportion of cases that have been morphologically verified, will be 
used to measure completeness of cancer registration in each population-based cancer 
registry.29,30 Additionally, data consistency will be assessed in-house through the 
comparison of annual incidence to long-term trends to detect unusual increases or decreases. 
Comparison with the pathology-based registry to identify data gaps will be essential. 
Regular reports of estimated national cancer incidence will be produced by the NCR using 
data from individual population-based cancer registries. These will be disseminated to 
individual population-based cancer registries, the Department of Health, other partners, and 
stakeholders, and will also be available online for public access.
The completeness of South Africa’s national death registration system has been rated as 
satisfactory with limitations noted in certification and coding of causes of death.31 Access to 
identifiable death notification data is crucial for the population-based cancer registries to 
compare data with the registry cancer reports. However, legislation pertaining to the 
confidentiality of death certificates has presented challenges in accessing this information. 
The NCR is in negotiations with the relevant authorities to help facilitate this process. 
Important aspects of this negotiation will be the Regulations Relating to Cancer 
Registration,22 which gives the NCR permission to collect all information about cancer in 
the country, and the security and confidentiality measures in place to safeguard data. Once 
the population-based cancer registry programme is granted access to this mortality data, the 
death certificate method of calculating completeness will be applied.29
Validity and comparability of data will be assessed using methods described in previously 
published work.30 The registry will aim to publish cancer incidence data for the country 
within a worldwide accepted lag period of 3–5 years.25 Additionally, guidance on the 
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monitoring and assessment of registry activities will be sought from the African Cancer 
Registry Network and its partner registries.
Lessons learned
The prioritisation of cancer, public–private partnerships, and effective leadership has been 
essential to the revival of the pathology-based registry and the implementation of 
population-based cancer registries in South Africa. The introduction of legislation, the 
establishment of the National Advisory Committee on Cancer Prevention and Control, and 
support from the National Department of Health has been invaluable in ensuring the 
evolution of these processes. Although drafting legislation for cancer surveillance 
programmes is a local matter, international expertise in the design of the data collection 
form would have been constructive. In addition, piloting the design of the collection form 
before formal declaration of the legislation would have been beneficial to help with 
implementation of data collection.
The NCR has learned that although the support of cancer surveillance legislation is essential 
for establishing the registry, it is insufficient on its own to guarantee stakeholder 
engagement. Considerable relationship-building, networking, and stakeholder consultation 
with health-care professionals has been necessary. In this regard, support from the oncology 
community has been very important in creating and maintaining these partnerships.
A common understanding among stakeholders (including politicians, Department of Health 
officials, cancer surveillance staff, and academics) of the definition of population-based 
registration, the scope of the registration area (national vs regional), the climate and 
environment within which the registry is operating (eg, cooperation from health-care 
workers), and the resources needed to establish the population-based cancer registry 
programme is essential. Many delays can be avoided if there is a mutual understanding 
among all partners and stakeholders at the beginning of the process, which will in turn lend 
itself to the development of a shared vision that is supported and accepted by all included.
Conclusion
As the future of cancer surveillance in South Africa lies in the establishment of a network of 
nationally representative, population-based cancer registries, the National Department of 
Health and the South African NCR are working to establish population-based cancer 
surveillance in four regions of the country, strategically chosen to replicate the diversity of 
the national population. The population-based registries will run in parallel with the 
established pathology-based cancer surveillance system, which has produced national cancer 
incidence data for the past 28 years. We expect that these simultaneous efforts will provide a 
robust and efficient cancer surveillance system in South Africa.
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Table
Cancer-related specialists registered with the Health Professions Council of South Africa, 2014
Number Per 10 000 population
Medical oncologists 33 0·006
Paediatric medical oncologists 20 0·01
Radiation oncologists 201 0·04
Pathologists (anatomical) 258 0·05
Ratios calculated using statistics from the South Africa mid-year population estimates for 2014; paediatric population includes all children aged 0–
14 years.4 Information courtesy of the Health Professions Council of South Africa.
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